HRT Financial’s Meridian Bioscience Inc VIVO Stock Holding History

HRT Financial’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-43,260	Closed	-$1.44M	–	3577
2022 Q4	$1.44M	Buy	+43,260	New	+$1.39M	0.02%	740
2022 Q3	–	Sell	-21,515	Closed	-$654K	–	3784
2022 Q2	$654K	Buy	21,515 +10,520	+96%	+$285K	0.01%	1295
2022 Q1	$285K	Buy	10,995 +731	+7%	+$17.4K	﹤0.01%	2269
2021 Q4	$209K	Sell	10,264 -9,772	-49%	-$187K	﹤0.01%	2507
2021 Q3	$385K	Buy	+20,036	New	+$399K	﹤0.01%	2237
2019 Q4	–	Sell	-14,555	Closed	-$138K	–	1798
2019 Q3	$138K	Buy	+14,555	New	+$153K	0.01%	1214

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HRT Financial's VIVO Position: Q1 2023 in Review

HRT Financial sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 43,260 shares — an estimated $1.44M sold.

HRT Financial first reported a position in VIVO in Q3 2019 and held it in 6 quarters. The position peaked at $1.44M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

HRT Financial reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
HRT Financial sold 43,260 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.44M.
HRT Financial first reported a position in Meridian Bioscience Inc in Q3 2019 and held it in 6 quarters.
HRT Financial's Meridian Bioscience Inc position peaked at $1.44M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.